STOCKHOLDERS' EQUITY (Details Narrative) - USD ($) |
3 Months Ended | |
---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
R&D [Member] | ||
Total expensed for equity compensation | $ 34,648 | $ 77,383 |
G&A [Member] | ||
Total expensed for equity compensation | 77,456 | 164,719 |
Members Of The Board Of Directors [Member] | ||
Total expensed for equity compensation | 112,104 | $ 242,102 |
20 private unregistered [Member] | ||
Proceed from stock issuances | $ 1,103,326 | |
Issuance of shares of common stock | 407,299 | |
Common stock sold to related parties | 56,666 | |
Proceed from Common stock sold to related parties | $ 130,782 |
X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|